ACR appropriateness Criteria® diffuse large b-cell lymphoma

Bouthaina S. Dabaja, Ranjana Advani, David C. Hodgson, Sughosh Dhakal, Christopher R. Flowers, Chul S. Ha, Bradford S. Hoppe, Nancy P. Mendenhall, Monika L. Metzger, John P. Plastaras, Kenneth B. Roberts, Ronald Shapiro, Sonali M. Smith, Stephanie A. Terezakis, Karen M. Winkfield, Anas Younes, Louis S. Constine

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

The management of diffuse large B-cell lymphoma depends on the initial diagnosis including molecular and immunophenotypic characteristics, Ann Arbor staging, and International Prognostic Index (IPI score). Treatment approaches with different chemotherapy regimens used is discussed in detail. The role of radiation as a consolidation is discussed including: (1) the prerituximab randomized trials that challenged the role of radiation, (2) recent prospective studies (UNFOLDER/RICOVER-60), and (3) retrospective studies; the last 2 showed a potential benefit of radiation both for early and advanced stage. The document also discusses the role of positron emission tomography/computed tomography for predicting outcome and potentially guiding therapy. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peerreviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Original languageEnglish (US)
Pages (from-to)610-620
Number of pages11
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume38
Issue number6
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Keywords

  • Appropriateness criteria
  • Large B-cell lymphoma
  • Lymphoma
  • Non-Hodgkin's lymphoma
  • Radiation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'ACR appropriateness Criteria® diffuse large b-cell lymphoma'. Together they form a unique fingerprint.

  • Cite this

    Dabaja, B. S., Advani, R., Hodgson, D. C., Dhakal, S., Flowers, C. R., Ha, C. S., Hoppe, B. S., Mendenhall, N. P., Metzger, M. L., Plastaras, J. P., Roberts, K. B., Shapiro, R., Smith, S. M., Terezakis, S. A., Winkfield, K. M., Younes, A., & Constine, L. S. (2015). ACR appropriateness Criteria® diffuse large b-cell lymphoma. American Journal of Clinical Oncology: Cancer Clinical Trials, 38(6), 610-620. https://doi.org/10.1097/COC.0000000000000215